Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Health Care Poor Underserved. 2018;29(3):1153–1175. doi: 10.1353/hpu.2018.0085

Table 3.

Prevalence ratios and 95% confidence intervals for not initiating HIV care within 3 monthsa, Florida, 2014–2015

Characteristic Model 1b (Race/ethnicity only) Crude PR (95% CI) Model 2b (Individual-level variables but not HIV testing site) Adjusted PR (95% CI) Model 3b (Individual- level variables and HIV testing site type) Adjusted PR (95% CI) Model 4b (Individual- and ZCTA-level variables and testing site type) Adjusted PR (95% CI)
Individual-level variables
Race/ethnicity
 Non-Hispanic black 1.75 (1.55–1.97) 1.72 (1.52–1.94) 1.66 (1.47–1.88) 1.57 (1.38–1.78)
 Hispanic 1.16 (1.00–1.33) 1.24 (1.06–1.44) 1.17 (1.00–1.36) 1.14 (0.98–1.33)
 Non-Hispanic white Referent Referent Referent Referent
Sex at birth
 Male 1.44 (1.27–1.64) 1.30 (1.14–1.47) 1.31 (1.15–1.48)
 Female Referent Referent Referent
Age group at diagnosis
 13–19 years Referent Referent Referent
 20–39 years 0.97 (0.82–1.16) 1.01 (0.85–1.20) 1.00 (0.85–1.19)
 40–59 years 0.71 (0.59–0.87) 0.80 (0.66–0.97) 0.79 (0.65–0.96)
 60 years or older 0.70 (0.55–0.90) 0.87 (0.68–1.11) 0.86 (0.67–1.09)
US- vs. foreign-born
 US bornc 1.23 (1.10–1.37) 1.21 (1.09–1.35) 1.21 (1.08–1.34)
 Foreign born Referent Referent Referent
Mode of HIV transmission
 Heterosexual contact Referent Referent Referent
 Male-to-male sexual contact (MSM) 0.68 (0.60–0.77) 0.72 (0.64–0.81) 0.73 (0.65–0.82)
 Injection drug use (IDU)d 1.12 (0.93–1.35) 1.14 (0.94–1.38) 1.14 (0.94–1.37)
 Other/unknown 1.70 (1.51–1.91) 1.57 (1.40–1.76) 1.58 (1.41–1.77)
AIDS diagnosis within 3 months of HIV diagnosis
 Yes Referent Referent Referent
 No 38.16 (21.76–66.91) 33.10 (19.00–57.66) 33.05 (18.98–57.54)
Year HIV diagnosed
 2014 Referent Referent Referent
 2015 0.86 (0.79–0.94) 0.87 (0.80–0.95) 0.87 (0.80–0.95)
Type of HIV test site
 Outpatient Referent Referent
 Hospitale 1.04 (0.87–1.23) 1.04 (0.87–1.23)
 Case management and counseling and testing site 1.63 (1.45–1.83) 1.62 (1.44–1.81)
 Blood bank/plasma center 2.49 (2.23–2.79) 2.45 (2.19–2.74)
 Otherf 1.37 (1.17–1.61) 1.36 (1.16–1.60)
ZCTA-level variables
SES index, quartilesg
 1 (lowest SES) Referent
 2 0.91 (0.81–1.03)
 3 0.88 (0.76–1.02)
 4 (highest SES) 0.90 (0.77–1.05)
Non-Hispanic black density (% of total population)
 <25% Referent
 25-49% 1.06 (0.93–1.20)
 ≥50% 1.08 (0.95–1.23)
RUCA classification
 Rural 1.20 (0.92–1.56)
 Urban Referent

Abbreviations: AIDS: acquired immune deficiency syndrome; C & T: counseling and testing; HIV: human immunodeficiency virus; RUCA: Rural-Urban Commuting Area; SES: socioeconomic status; US: United States; ZCTA: ZIP code tabulation area.

Note:

a

Did not meet care initiation definition: within 3 months of HIV diagnosis a documented laboratory result (cluster of differentiation4 immune cell [CD4] count or viral load), medical visit, or antiretroviral prescription as ascertained through the Enhanced HIV/AIDS Reporting System, AIDS Drug Assistance Program database, or in the Florida Department of Health HIV services databases.

b

The Quasilikelihood under the Independence Model Criterion (QIC) was 10,576.77 for model 1; 9,702.52 for model 2, 9,524.39 for model 3 and 9,531.12 for model 4.

c

Category includes cases born in any of the 50 US states, District of Columbia, or any US dependency.

d

Includes cases with mode of transmission reported as injection drug use or injection drug use with male-to-male sexual contact.

e

Hospital includes any hospital department (e.g. inpatient, emergency department)

f

Other/unknown screening site includes laboratory, drug treatment center, other, and missing.

g

Quartiles of standardized SES scores for Florida ZCTAs.